USAID Grant: NPI THRIVE for Collaborative HIV Vaccine Research

The United States Agency for International Development (USAID) is seeking applications for cooperative agreements from qualified entities to implement activities under the Translational HIV Research for Innovative Vaccines Ecosystem (NPI THRIVE) Program. NPI-THRIVE is a New Partnerships Initiative (NPI) Activity, meaning it encourages the use of innovative, locally-led approaches with new, nontraditional, and local partners. Eligibility for these awards is not restricted. The overall goal of NPI THRIVE is to accelerate the development of a safe and globally effective HIV vaccine by supporting a collaborative research ecosystem led by scientists and institutions from countries in Africa with high burdens of HIV working in close partnership with leading scientific institutions from other regions. This will be achieved through pursuing two complementary objectives, one focusing on clinical research and the other on preclinical research.

USAID intends to award at least two Applicants, at least one for each of the two objectives of this funding opportunity, based on the merit review criteria described in this NOFO and subject to a risk assessment. Parties interested in applying are encouraged to read this NOFO thoroughly to understand the type of program sought, application submission requirements, and selection process. This funding opportunity is posted on www.grants.gov, and may be amended. It is the Applicant’s responsibility to regularly check the website to ensure they have the latest information pertaining to this NOFO and to ensure that the NOFO has been received from the internet in its entirety. USAID bears no responsibility for data errors resulting from transmission or conversion processes. If you have difficulty registering on www.grants.gov or accessing the NOFO, please contact the Grants.gov Helpdesk at 1-800-518-4726 or via email at support@grants.gov for technical assistance.

The United States Agency for International Development (USAID) is seeking applications for cooperative agreements from qualified entities to implement activities under the Translational HIV Research for Innovative Vaccines Ecosystem (NPI THRIVE) Program. NPI-THRIVE is a New Partnerships Initiative (NPI) Activity, meaning it encourages the use of innovative, locally-led approaches with new, nontraditional, and local partners. Eligibility for these awards is not restricted. The overall goal of NPI THRIVE is to accelerate the development of a safe and globally effective HIV vaccine by supporting a collaborative research ecosystem led by scientists and institutions from countries in Africa with high burdens of HIV working in close partnership with leading scientific institutions from other regions. This will be achieved through pursuing two complementary objectives, one focusing on clinical research and the other on preclinical research.

USAID intends to award at least two Applicants, at least one for each of the two objectives of this funding opportunity, based on the merit review criteria described in this NOFO and subject to a risk assessment. Parties interested in applying are encouraged to read this NOFO thoroughly to understand the type of program sought, application submission requirements, and selection process. This funding opportunity is posted on www.grants.gov, and may be amended. It is the Applicant’s responsibility to regularly check the website to ensure they have the latest information pertaining to this NOFO and to ensure that the NOFO has been received from the internet in its entirety. USAID bears no responsibility for data errors resulting from transmission or conversion processes. If you have difficulty registering on www.grants.gov or accessing the NOFO, please contact the Grants.gov Helpdesk at 1-800-518-4726 or via email at support@grants.gov for technical assistance.

The United States Agency for International Development (USAID) is seeking applications for cooperative agreements from qualified entities to implement activities under the Translational HIV Research for Innovative Vaccines Ecosystem (NPI THRIVE) Program. NPI-THRIVE is a New Partnerships Initiative (NPI) Activity, meaning it encourages the use of innovative, locally-led approaches with new, nontraditional, and local partners. Eligibility for these awards is not restricted. The overall goal of NPI THRIVE is to accelerate the development of a safe and globally effective HIV vaccine by supporting a collaborative research ecosystem led by scientists and institutions from countries in Africa with high burdens of HIV working in close partnership with leading scientific institutions from other regions. This will be achieved through pursuing two complementary objectives, one focusing on clinical research and the other on preclinical research.

USAID intends to award at least two Applicants, at least one for each of the two objectives of this funding opportunity, based on the merit review criteria described in this NOFO and subject to a risk assessment. Parties interested in applying are encouraged to read this NOFO thoroughly to understand the type of program sought, application submission requirements, and selection process. This funding opportunity is posted on www.grants.gov, and may be amended. It is the Applicant’s responsibility to regularly check the website to ensure they have the latest information pertaining to this NOFO and to ensure that the NOFO has been received from the internet in its entirety. USAID bears no responsibility for data errors resulting from transmission or conversion processes. If you have difficulty registering on www.grants.gov or accessing the NOFO, please contact the Grants.gov Helpdesk at 1-800-518-4726 or via email at support@grants.gov for technical assistance.